Cargando…

Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients

BACKGROUND AND OBJECTIVES: The prognostic or safety implication of renin-angiotensin-aldosterone system inhibitors (RASi) in hypertrophic cardiomyopathy (HCM) are not well established, mainly due to concerns regarding left ventricular outflow tract (LVOT) obstruction aggravation. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Chan Soon, Rhee, Tae-Min, Lee, Hyun Jung, Yoon, Yeonyee E., Park, Jun-Bean, Lee, Seung-Pyo, Kim, Yong-Jin, Cho, Goo-Yeong, Hwang, In-Chang, Kim, Hyung-Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475688/ https://www.ncbi.nlm.nih.gov/pubmed/37653696 http://dx.doi.org/10.4070/kcj.2023.0035

Ejemplares similares

Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
por: Park, Jae-Hyeong
Publicado: (2023)

Comparison of mortality and cause of death between adults with and without hypertrophic cardiomyopathy
por: Kwon, Soonil, et al.
Publicado: (2022)

Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic cardiomyopathy: A preliminary comparative study
por: Park, Jiesuck, et al.
Publicado: (2023)

Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy
por: Rodriguez-Gonzalez, Moises, et al.
Publicado: (2020)

Impact of coronary artery revascularization on long-term outcome in hypertrophic cardiomyopathy patients: a nationwide population-based cohort study
por: Rhee, Tae-Min, et al.
Publicado: (2023)

Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort
por: Lee, Heesun, et al.
Publicado: (2022)

Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study
por: Moon, Inki, et al.
Publicado: (2020)

Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study
por: Lee, Heesun, et al.
Publicado: (2019)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2022)

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea
por: Park, Jungchan, et al.
Publicado: (2021)

Sex differences in the prognosis of patients with hypertrophic cardiomyopathy
por: Kim, Minkwan, et al.
Publicado: (2021)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
por: Kang, Si-Hyuck, et al.
Publicado: (2021)

Effect of Renin−Angiotensin−Aldosterone System Blockade on Outcomes in Patients With ESRD: A Prospective Cohort Study in Korea
por: Yoo, Kyung Don, et al.
Publicado: (2018)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
por: Choi, You-Jung, et al.
Publicado: (2022)

Effects of Renin-Angiotensin-Aldosterone System Inhibition on Left Ventricular Hypertrophy, Diastolic Function, and Functional Status in Patients With Hypertrophic Cardiomyopathy: A Systematic Review
por: Akhtar, Hamza, et al.
Publicado: (2022)

Efficacy and safety of supramaximal titrated inhibition of renin‐angiotensin‐aldosterone system in idiopathic dilated cardiomyopathy
por: He, Zheng, et al.
Publicado: (2015)

Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System
por: Maris, Stephen A, et al.
Publicado: (2019)

Erratum for The renin‐angiotensin‐aldosterone system and its suppression
Publicado: (2019)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review
por: Laghlam, Driss, et al.
Publicado: (2021)

Emergency department utilization in patients with hypertrophic cardiomyopathy: a nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_picmu27jnldbrq3p4lhpk4924p